How Might Current Data Inform the Primary Care Physician’s and the Multidisciplinary Team’s Management of Cardiorenal Risk in Patients with Chronic Kidney Disease and Type 2 Diabetes?
Post-Test/Evaluation

Exit Survey
Questions marked with a * are required
20%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Ronald is a 62-year-old man with a history of T2D. Lab results show eGFR of 43 mL/min/1.73m2 +  serum K+ of 4.8mEq/L. He is currently taking finerenone10 mg QD. How would you manage the hyperkalemia in this patient?
The pillars of therapy to reduce cardiorenal risk include (Select all that apply)
Spironolactone has _____ selectivity to MR, a _____ half-life and _____ effect on BP compared with finerenone.
Powered by QuestionPro